Loading financials from SEC filings…
Specialty industrial machinery · Industrials · Fiscal year ends Dec 31
Gorman Rupp reported revenue of $682M in the fiscal year ended Dec 2025, up 3.4% from the year before. Operating income was $95M, an operating margin of 14.0%, and net income was $53M. Operating cash flow of $106M less capital expenditure of $17M left free cash flow of $89M. Net debt was $272M.
Ranks among the 35 specialty industrial machinery companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 378 | 521 | 660 | 660 | 682 |
| Cost of revenue | 282 | 390 | 463 | 455 | 473 |
| Gross profit | 95.9 | 131 | 196 | 204 | 209 |
| Selling, general & admin | 56.0 | 83.1 | 96.7 | 101 | 101 |
| Operating income | 39.4 | 40.2 | 87.0 | 91.4 | 95.4 |
| Interest expense | 0.0 | 19.2 | 41.3 | 33.6 | 23.4 |
| Pre-tax income | 37.2 | 13.9 | 44.0 | 50.5 | 69.2 |
| Income tax | 7.4 | 2.7 | 9.0 | 10.4 | 16.1 |
| Net income | 29.9 | 11.2 | 35.0 | 40.1 | 53.0 |
| Diluted EPS | 1.14 | 0.43 | 1.34 | 1.53 | 2.02 |
| Diluted shares | – | – | 26.2 | 26.2 | 26.3 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 125 | 6.8 | 30.5 | 24.2 | 35.1 |
| Receivables | 58.5 | 93.1 | 89.6 | 87.6 | 88.4 |
| Inventory | 85.6 | 111 | 104 | 99.2 | 96.5 |
| Current assets | 277 | 226 | 236 | 221 | 234 |
| Net PP&E | 104 | 129 | 135 | 132 | 134 |
| Goodwill | 27.2 | 258 | 258 | 258 | 258 |
| Total assets | 421 | 873 | 890 | 858 | 860 |
| Payables | 17.6 | 24.7 | 23.9 | 24.8 | 25.9 |
| Deferred revenue | 9.2 | 6.7 | 12.5 | 6.8 | 7.7 |
| Current liabilities | 52.4 | 85.2 | 101 | 87.5 | 98.6 |
| Short-term debt | 0.0 | 17.5 | 21.9 | 18.5 | 23.1 |
| Long-term debt | 0.0 | 419 | 383 | 348 | 284 |
| Total liabilities | 90.8 | 542 | 541 | 485 | 445 |
| Shareholders' equity | 330 | 331 | 349 | 374 | 415 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 45.4 | 13.7 | 98.2 | 69.8 | 106 |
| Capital expenditure | 9.8 | 18.0 | 20.8 | 14.3 | 17.4 |
| Free cash flow | 35.7 | −4.3 | 77.4 | 55.5 | 88.9 |
| Depreciation & amortisation | 11.9 | 21.2 | 28.5 | 27.9 | 27.7 |
| Stock-based compensation | 2.4 | 3.0 | 3.3 | 4.0 | 3.6 |
| Dividend per share | 0.64 | – | – | – | – |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 37.7% | 26.6% | 0.0% | 3.4% |
| Operating income growth (YoY) | – | 2.1% | 116.6% | 5.1% | 4.3% |
| EPS growth (YoY) | – | −62.3% | 211.6% | 14.2% | 32.0% |
| Gross margin | 25.3% | 25.1% | 29.8% | 31.0% | 30.6% |
| Operating margin | 10.4% | 7.7% | 13.2% | 13.9% | 14.0% |
| Net margin | 7.9% | 2.1% | 5.3% | 6.1% | 7.8% |
| Return on equityBlank when equity is negative | 9.0% | 3.4% | 10.0% | 10.7% | 12.8% |
| ROCEEBIT ÷ (assets − current liabilities) | 10.7% | 5.1% | 11.0% | 11.9% | 12.5% |
| Free cash flow margin | 9.4% | −0.8% | 11.7% | 8.4% | 13.0% |
| Cash conversion (CFO ÷ net income) | 1.52x | 1.22x | 2.81x | 1.74x | 2.00x |
| Receivable days | 56 | 65 | 50 | 48 | 47 |
| Inventory days | 111 | 104 | 82 | 80 | 74 |
| Payable days | 23 | 23 | 19 | 20 | 20 |
| Interest cover | – | 2.09x | 2.11x | 2.72x | 4.08x |
| Debt ÷ equity | 0.00x | 1.32x | 1.16x | 0.98x | 0.74x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | −125 | 430 | 374 | 342 | 272 |
| Current ratio | 5.29x | 2.65x | 2.35x | 2.52x | 2.37x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.